Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients

Published 2016 View Full Article

Authors

Keywords

anti-drug antibodies, dashboards, decision support tools, inflammatory bowel disease, infliximab, personalized medicine, therapeutic monitoring, trough concentrations

Journal

AAPS Journal

Volume 19, Issue 1, Pages 215-222

Publisher

American Association of Pharmaceutical Scientists (AAPS)

Online

2016-10-14

DOI

10.1208/s12248-016-9994-y

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More